Our data correlate with previous studies showing better response to cisplatin treatment in breast cancer patients with low BRCA1 levels [29, 36], and studies showing increased BRCA1 expression in breast cancer cells after treatment with 1, 25D or vitamin D analogues [37–38]. Here, BRCA1 is linked to breast carcinoma.